Nerac

Information That Drives Innovation

We’re here to help with your research needs
+1 860 872 7000
Customer Access
  • Home
  • What We Do
    • Innovation Insights and Consulting Practice
    • Regulatory
    • Medical Device and Life Sciences
    • Technology Scouting and Innovation
    • Market Research
    • Intellectual Property
    • Commercialization Services for TTOs and Start-Ups
    • Critical Updates
  • Who We Serve
  • How to Engage
  • Why Nerac?
  • Meet our Team
    • Leadership Team
    • Our Analysts
    • Our Partners
  • Nerac Insights and Publications
    • Articles
    • Case Studies
    • Press Room
    • Videos
    • Webcasts
    • White Papers
  • Contact Us
You are here: Home / Nerac Insights / Articles / Seal the Deal. Avoid these common corporate development mistakes.

Seal the Deal. Avoid these common corporate development mistakes.

Facebook0
Google+0
LinkedIn1
Twitter0

By Kevin Closson Nerac Analyst,
Originally Published: July 23, 2014

Corporate development is extremely risky. The stats from numerous studies are dismal:

  • Anywhere between 50 percent and 90 percent of acquisitions fail to live up to financial expectations;
  • Mergers fail between 50 percent and 85 percent of the time;
  • Joint ventures are only slightly less dreary; they fall apart between 30 percent and 60 percent of the time.

Yet despite these bleak odds, companies and the executives running them remain undeterred. The overwhelming majority of successful private company exits in 2012 and 2013 were not IPOs but rather mergers, acquisitions or sales. This is a historical trend that is unlikely to change in the future.

Want to read the rest of the article? Fill out the form to download: Seal the Deal. Avoid these common corporate development mistakes.
Get Download Link

 

Related Posts

  • Three Business Decisions Made Smarter Through Patent Valuation
    82
    By Kevin Closson, Nerac Analyst Originally Published: July 23, 2014 Making smarter, better decisions is something everybody wants to do. Shelves of books and mountains of research papers have been written on decision making from every possible angle. Fundamentally, though, decision making is about comparing the various options and selecting the best one. “Best” could mean…
    Tags: read, closson, kevin, analyst, nerac, patent, valuation, article, full, things
  • Nerac Announces Patent Webinar Series
    77
    Webinars Address Patent Fundamentals, Best Practices, Patent Landscape and Patent Valuation Read the full release here.
    Tags: patent, read, full, valuation, nerac
  • Product Patents: Investigating the Patents behind Products on the Market
    54
    By Stephenie Smulligan-Maldanis, M.S., Nerac Analyst, Originally Published: May 25th, 2015 What patent covers this product?  When does the patent expire?  What is the assignee history?  The answers to these and related questions are often critical parts of making business decisions and are also questions often posed to Nerac analysts.
    Tags: patents, nerac, read, patent, analyst, article
  • Case Studies
  • White Papers
  • Webcasts
  • Articles
    • Nerac Strategist
    • Energy
    • Food & Nutrition
    • Intellectual Property
    • Regulatory
    • Technology & Innovation
    • Medical Device & Healthcare
    • Pharmaceutical
    • Engineering
    • Market Research
    • Critical Alerts
    • Chemistry/Advanced Materials
  • Press Room

Click here to learn more about….

3d printing advanced materials aerospace Ask Kevin Videos biotech CFDA clinical literature evaluations commercialization strategies competitive intelligence conflict minerals Disruptive Technologies emerging markets energy EU MDR FDA food Industry 4.0 innovation Inspiring Next intellectual property intellectual property strategies IP market analysis market research medical device medical devices nerac Nerac client questions Nerac Strategist notified body audit open innovation Order 650 patenting strategies patent landscape pharmaceutical Post-Market Surveillance R&D regulatory regulatory compliance Robert Beinstein Rosemarie Szostak specialty chemicals Sustainable Development Goals technology scouting XcellR8
  • Facebook
  • Google+
  • Linkedin
  • RSS
  • Twitter
  • YouTube
  • Career Opportunities

Copyright © 2021 Nerac · One Technology Drive · Tolland, CT 06084 · 1.860.872.7000

Sign Up for the Nerac Strategist

Like what you see? Sign up here to receive the Nerac Strategist newsletter, a compilation of analyst insights on rapidly developing industry issues, compliance challenges and commercial opportunities!
  • This field is for validation purposes and should be left unchanged.